Online Resources-Online.doc-20000613a-Online-doc

Online Resources

KFF Resources

Daily Reproductive Health Reports on RU-486 and Mifepristone
Offers a retrospective look at the debate, using the archives of this daily report.

Abortion, Issue Update
May 1999 Highlights the clinical and political issues regarding abortion.

From the Patient’s Perspective: the Quality of Abortion Care
May 1999 – Women’s views and perceptions of the quality of care they have received.

Abortion in the U.S., Fact Sheet
September 1998 – Offers some useful background statistics on abortion in the United States.

Will 1999 Be The Year For Mifepristone (RU-486) And, An Update on Women’s Other Options for Very Early Abortion, Q & A
September 16, 1998 – Examines some of the questions regarding Mifepristone.

National Survey of Women’s Health Care Providers on Medical Abortion
September 16, 1998 – Examined provider views of Medical abortion techniques, such as Mifepristone.

Content Analysis: Sexual Health Coverage in Women’s, Men’s and Teen Magazines
April 1997 – An assessment of magazine content, specifically looking at how these specialty magazines dealt with such subjects as abortion.

General Background

American Medical Association – Publications list on Mifepristone.

FDA Approvable Letter for Mifepristone
February 18, 2000 – According to the FDA: “An approvable letter does not give a company permission to begin marketing the drug.” The FDA issued a prior approvable letter for mifepristone to the “Population Council in September 1996, indicating that the agency believed the drug to be safe and effective, but that unresolved issues remained, including questions about manufacturing.”

FDA Archives on Mifepristone – Offers information from FDA on-line files regarding this controversial drug.

FDA Consumer Magazine – Mifepristone – This update from May/June 2000 offers some information on the approval process.

Medline search on Mifepristone – articles from various journals .

Merck Manual Home Edition – Information Family Planning Methods, including background on medical abortion methods.

Mifepristone – Prescription Drug Reference on WebMD offers general information on the drug.

New England Journal of Medicine – Articles on Mifepristone.

The Recent Debate

Family Research Council Press Release – A pro-life perspective on FDA’s decision.

National Abortion and Reproductive Rights Action League Press Release – A pro-choice perspective.

Organizations Involved in the Debate

Alan Guttmacher Institute – reproductive health research, policy analysis and public education.

American Civil Liberties Union (ACLU) Reproductive Rights Project – Site features information on reproductive rights in Congress and other related legal issues such as privacy and equality.

American Life League – a pro-life organization.

Center for Reproductive Law and Policy (CRLP) – independent, non-profit legal organization “dedicated to promoting women’s health and rights.”

Life Issues Institute – a pro-life organization that seeks to assure “equal protection under the law for all living humans.”

National Right to Life Committee – a public policy group that is dedicated to “the protection of all human life.”

National Abortion Federation (NAF) – A professional association of abortion providers in the United States, providing information on options for pregnant women, information on abortion issues and violence at clinics, as well as fact sheets for providers.

Pacific Institute for Women’s Health – a group dedicated to improving women’s health through research, advocacy, community involvement, consultation, and training.

Planned Parenthood Federation of America – a national family planning organization that supports the use of Mifepristone.

Sexuality Information and Education Council of the U.S. – Promotes comprehensive education about sexuality, and advocates the right of individuals to “make responsible sexual choices.”

Women’s Reproductive Health Resources

American College of Obstetricians & Gynecologists (ACOG) – Site provides fact sheets on all aspects of women’s reproductive health, including abortion.

Association of Reproductive Health Professionals – Organization dedicated to educating health care professionals and the public on family planning, contraception and other reproductive health issues.

FDA’s Office of Women’s Health – A site for medical professionals and women, which offers various obstetrical and gynecological information resources.

Society for Women’s Health Research – Offers a reading list on women’s health issues, including publications on abortion.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.